Profesor Invitado: Dr. Juan Carlos Ramírez Sandoval
Especialista en Nefrología
Objetivo de Aprendizaje:
- Reconocer la subestimación y subdiagnóstico de la hipercalemia, así como su impacto en la práctica clínica.
- Analizar las consecuencias de la suspensión de terapias como los iSRAA, en términos de pronóstico cardiorrenal.
- Identificar la importancia de implementar estrategias de control del potasio que permitan mantener la continuidad del tratamiento y optimizar los resultados clínicos.
Referencias:
- Alfonzo A, et al. Clinical practice guidelines. Treatment of acute hyperkalaemia in adults. 2023. https://www.ukkidney.org/sites/default/files/FINAL%20VERSION%20-%20UKKA%20CLINICAL%20PRACTICE%20GUIDELINE%20-%20MANAGEMENT%20OF%20HYPERKALAEMIA%20IN%20ADULTS%20-%20191223_0.pdf
- American Heart Association. Part 10.1: Life-threatening electrolyte abnormalities. 2005. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.105.166563
- National Kidney Foundation. Best practices in managing hyperkalemia in chronic kidney disease. 2016. https://www.kidney.org/sites/default/files/02-10-7259_DBH_Best-Practices-in-Managing-Hyperkalemia-in-CKD.pdf
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024 Apr;105(4S):S117-S314.
- Howlett JG, et al. The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice. Can J Cardiol. 2016 Mar;32(3):296-310.
- Rosano GMC, et al. Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology. Eur Heart J Cardiovasc Pharmacother. 2018 Jul 1;4(3):180-188.
- McDonagh TA, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: supplementary data. Eur Heart J. 2021 Sep 21;42(36):3599-3726.
- Larivée NL, et al. Hyperkalemia: Prevalence, Predictors and Emerging Treatments. Cardiol Ther. 2023 Mar;12(1):35-63.
- Kovesdy CP. Management of hyperkalaemia in chronic kidney disease. Nat Rev Nephrol. 2014 Nov;10(11):653-62.
- Vardeny O, et al. Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist. Circ Heart Fail. 2014 Jul;7(4):573-